Vaccinex, Inc.
VCNX· OTC
VCNXVaccinex, Inc.
Filed May 14, 2020 · 10-Q · 44 days after period end · 0001564590-20-025279
| Metric | Q1 2020 | Q1 2019 | Q1 2018 |
|---|---|---|---|
| Revenue | — | $94.00K | $206.00K |
| Net Income | -$7.15M | -$9.07M | -$7.86M |
| EPS Diluted | -$0.45 | -$0.79 | -$7.13 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vaccinex, Inc. · CIK 1205922 · Engraved from SEC EDGAR
ended Mar 31, 2020 · filed May 14, 2020 · 44 d after period end
